MedTrace Logo

Optimized vs. Standard Automated Peritoneal Dialysis Regimens Study

NCT04017572 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2021-02-12

No results posted yet for this study

Summary

This clinical study is designed to evaluate the theoretical prediction of a lower glucose absorption in optimized automated peritoneal dialysis regimes. Patients will receive both a standard 6 x 2L 1.36% glucose regime or an optimized 7 x 2 L 2.27% glucose + 5 x 2 L 0.1% glucose regime in a crossover fashion.

Conditions

Interventions

PROCEDURE

Automated peritoneal dialysis (APD)

Automated peritoneal dialysis (APD) using the Baxter HomeChoice Pro Cycler.

Sponsors & Collaborators

  • Universidad de Córdoba

    collaborator OTHER

  • Baxter Healthcare Corporation

    collaborator INDUSTRY

  • Lund University

    lead OTHER

Principal Investigators

  • Carl M Öberg, M.D., Ph.D. · Lund University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2020-09-30
Completion
2020-09-30

Countries

  • Argentina

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04017572 on ClinicalTrials.gov